Jazz Pharmaceuticals
Clinical trials sponsored by Jazz Pharmaceuticals, explained in plain language.
-
Safety check: monitoring liver health in patients taking seizure medication
Disease control OngoingThis study aims to monitor for potential long-term liver effects in people taking Epidiolex (cannabidiol) for severe seizure disorders. Researchers will follow 154 participants who are either already taking Epidiolex or starting it for FDA-approved conditions. The main goal is to…
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
Major trial tests new drug combo against aggressive stomach cancers
Disease control OngoingThis large Phase 3 study is testing whether a new drug combination works better than the current standard treatment for advanced HER2-positive stomach and esophageal cancers that cannot be removed by surgery. The trial will involve 920 patients and compares zanidatamab plus chemo…
Phase: PHASE3 • Sponsor: Jazz Pharmaceuticals • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC
-
Cannabis-Derived drug tested for brain symptoms in rare genetic disorder
Symptom relief OngoingThis study is checking if adding the prescription CBD medication Epidiolex to existing anti-seizure drugs helps improve behavior problems, sleep, and quality of life in people with tuberous sclerosis complex (TSC). It will include up to 79 participants, aged 1 to 65, who have TSC…
Phase: PHASE4 • Sponsor: Jazz Pharmaceuticals • Aim: Symptom relief
Last updated Mar 11, 2026 14:53 UTC